Yesterday via a premium tweet we stated, due to strong earnings of a stock that we have been holding for over two years, we would aggressively add to our long position – a testament that patience, discipline and conviction pays […]
Summary Trading at less than a quarter of valuation of its closest peer that was acquired by Roche in August 2014, Marina Biotech is extremely undervalued. News in the RNA therapeutics sector continues to attract strong attention; most recently in […]
There is no excerpt because this is a protected post.
Ibio (AMEX:IBIO) Price Movement From Ebola/Enterovirus Hype Ibio (AMEX:IBIO) ($1.47) is a leading provider of plant-based biotechnology for developing and manufacturing biological products. As expected, the hype surrounding the Ebola and Enterorvirus outbreaks in the U.S. will inevitably led to aggressive share price […]
Summary REPR’s flagship product has a firm grip on the growing infusion homecare market and REPR’s stock is trading at a significant discount to what it’s worth. The product is held in high regard by those in the industry, who […]
Summary We believe Stellar Biotechnologies’ (SBOTF) share price to be a product of a well timed promotional campaign. SBOTF’s share count has risen 88.2% in three short years and the September 2013 PIPE was done at a fully diluted share […]
Call(s) to Action: ISNS ISNS ($6.40) – Covered our short position; stock has dropped roughly 30% since we alerted members of short thesis article. Moving on to other opportunities. Here are the other stories that the GeoTeam is following today… […]
Call(s) to Action: This morning we stated: GeoBargain on the radar CRTN (old symbol TMNG)($4.16) – Appears the company has come through with a breakout quarter. We have been waiting for a quarter like this since the company embarked on […]